SlideShare a Scribd company logo
1 of 11
Potent Human Mesenchymal Stem Cells and Media

                   Capabilities and Competitive Analysis




                        www.neuromics.com
STEM CELL PRODUCTS
    Focus on Mesenchymal Stem Cells-Why MSCs?

• Numerous Clinical Uses:
       Joint disease & injury, autoimmunity, stroke, organ failure (heart,
         liver, kidney & lung), MS, promotion of HSC engraftment,
         regenerative medicine, cancer, hearing loss, etc.
• Readily Available:
       Blood, adipose (fat) tissue, bone marrow, teeth, etc
GFP-Expressing Human MSCs Catalog Number SC00A4




  Image: FITC of Single Human MSC GFP-Expressing Human MSCs
  express label in the cytoplasm.
Illustrates morphological detail of human mesenchymal stem cells.
GFP-Expressing Human MSCs




FITC Image           FITC + PC showing selection
Red Fluorescent Human Mesenchymal Stem Cells




    Self-Renewal        Transfer of label to
                        chondrocyte (25 mM
                        PGE2)
MSC Growth in Low Serum MSCGro™ Compared to Lonza MSC-GM




   MSCGroTM at Day 3          MSCGroTM at Day 4




    Lonza at Day 3           Lonza at Day 4
Human MSC Growth in MSCGroTM vs Competitors Media:
MSCGroTM results in faster growth & 2-3-fold greater cell recovery
160
                                    Real Time Stability of MSCGro
                      140           Compared to Competitor's Medium

                      120
Doubling Time (Hrs)




                      100                           MSCGro       at 5% O2
                                                    MSCM-ScienCell at 5% O2
                      80
                                                    MSCGro       at 20% O2
                      60                        (Adipose MSCs by third party)

                      40


                      20

                       0
                            0   1   2   3   4   5    6   7   8       9   10   11 12   13 14
                                                                 o
                                                 Months at 2-8 C
Humanized Complete & Humanized Powder MSCGro™
Differentiation of Human MSCs Cultured in MSC-GroTM Medium




Chondrocyte Stained   Adipocytes Stained with   Osteoblast Stained
  with Alcian Blue           Oil Red             with Alizarin Red
Competitive Advantages of MSCGroTM

• MSC growth rate/cell recovery > Lonza, InVitrogen, Stem Cell
  Technologies, ScienCell & ZenBio media.
• MSC quality/potency (Lumenesc™) > Lonza, InVitrogen and Stem Cell
  Technologies media.
• Vastly improved real time stability.
• Medium function unaffected by freezing.
• Out-performs competitors at both reduced & ambient O2
• Supports self-renewal of human, rat & mouse MSCs
• Also supports primary cultures: fibroblasts (human & rat); rat
  cardiomyocytes & possibly hepatocytes
• Provided complete & ready to use as is.

More Related Content

More from Pete Shuster

Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaPete Shuster
 
Neuromics base presentation 2020
Neuromics base presentation 2020Neuromics base presentation 2020
Neuromics base presentation 2020Pete Shuster
 
Neuromics base presentation 2019
Neuromics base presentation 2019Neuromics base presentation 2019
Neuromics base presentation 2019Pete Shuster
 
Human blood brain barrier
Human blood brain barrierHuman blood brain barrier
Human blood brain barrierPete Shuster
 
Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Pete Shuster
 
Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Pete Shuster
 
Neuron Glial Interactions
Neuron Glial InteractionsNeuron Glial Interactions
Neuron Glial InteractionsPete Shuster
 
Optimized Protocol for Sorting Cells
Optimized Protocol for Sorting CellsOptimized Protocol for Sorting Cells
Optimized Protocol for Sorting CellsPete Shuster
 
Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm editsBiopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm editsPete Shuster
 
Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013Pete Shuster
 
Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012Pete Shuster
 
Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Pete Shuster
 
Arun A Neuromics Hca Hts Overview V3 04 26 2011
Arun A Neuromics Hca Hts Overview V3 04 26 2011Arun A Neuromics Hca Hts Overview V3 04 26 2011
Arun A Neuromics Hca Hts Overview V3 04 26 2011Pete Shuster
 
Neuromics Presentation V4
Neuromics Presentation V4Neuromics Presentation V4
Neuromics Presentation V4Pete Shuster
 

More from Pete Shuster (15)

Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport Media
 
Neuromics base presentation 2020
Neuromics base presentation 2020Neuromics base presentation 2020
Neuromics base presentation 2020
 
Neuromics base presentation 2019
Neuromics base presentation 2019Neuromics base presentation 2019
Neuromics base presentation 2019
 
Human blood brain barrier
Human blood brain barrierHuman blood brain barrier
Human blood brain barrier
 
Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014
 
Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13
 
Neuron Glial Interactions
Neuron Glial InteractionsNeuron Glial Interactions
Neuron Glial Interactions
 
Optimized Protocol for Sorting Cells
Optimized Protocol for Sorting CellsOptimized Protocol for Sorting Cells
Optimized Protocol for Sorting Cells
 
Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm editsBiopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
 
Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013
 
Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012
 
Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012
 
Arun A Neuromics Hca Hts Overview V3 04 26 2011
Arun A Neuromics Hca Hts Overview V3 04 26 2011Arun A Neuromics Hca Hts Overview V3 04 26 2011
Arun A Neuromics Hca Hts Overview V3 04 26 2011
 
Neuromics Presentation V4
Neuromics Presentation V4Neuromics Presentation V4
Neuromics Presentation V4
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 

Recently uploaded

Advanced Computer Architecture – An Introduction
Advanced Computer Architecture – An IntroductionAdvanced Computer Architecture – An Introduction
Advanced Computer Architecture – An IntroductionDilum Bandara
 
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfHyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfPrecisely
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc
 
DevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenDevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenHervé Boutemy
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsMiki Katsuragi
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsSergiu Bodiu
 
How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.Curtis Poe
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupFlorian Wilhelm
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningLars Bell
 
Leverage Zilliz Serverless - Up to 50X Saving for Your Vector Storage Cost
Leverage Zilliz Serverless - Up to 50X Saving for Your Vector Storage CostLeverage Zilliz Serverless - Up to 50X Saving for Your Vector Storage Cost
Leverage Zilliz Serverless - Up to 50X Saving for Your Vector Storage CostZilliz
 
Developer Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLDeveloper Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLScyllaDB
 
Story boards and shot lists for my a level piece
Story boards and shot lists for my a level pieceStory boards and shot lists for my a level piece
Story boards and shot lists for my a level piececharlottematthew16
 
Commit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easyCommit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easyAlfredo García Lavilla
 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfAlex Barbosa Coqueiro
 
Search Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfSearch Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfRankYa
 
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo DayH2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo DaySri Ambati
 
Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsMark Billinghurst
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):comworks
 
Artificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxArtificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxhariprasad279825
 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Scott Keck-Warren
 

Recently uploaded (20)

Advanced Computer Architecture – An Introduction
Advanced Computer Architecture – An IntroductionAdvanced Computer Architecture – An Introduction
Advanced Computer Architecture – An Introduction
 
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfHyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
 
DevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenDevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache Maven
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering Tips
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platforms
 
How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project Setup
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine Tuning
 
Leverage Zilliz Serverless - Up to 50X Saving for Your Vector Storage Cost
Leverage Zilliz Serverless - Up to 50X Saving for Your Vector Storage CostLeverage Zilliz Serverless - Up to 50X Saving for Your Vector Storage Cost
Leverage Zilliz Serverless - Up to 50X Saving for Your Vector Storage Cost
 
Developer Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLDeveloper Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQL
 
Story boards and shot lists for my a level piece
Story boards and shot lists for my a level pieceStory boards and shot lists for my a level piece
Story boards and shot lists for my a level piece
 
Commit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easyCommit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easy
 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdf
 
Search Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfSearch Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdf
 
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo DayH2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
 
Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR Systems
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):
 
Artificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxArtificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptx
 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024
 

H ms cs_capabilities_competitive_analysis_ 7-11-12

  • 1. Potent Human Mesenchymal Stem Cells and Media Capabilities and Competitive Analysis www.neuromics.com
  • 2. STEM CELL PRODUCTS Focus on Mesenchymal Stem Cells-Why MSCs? • Numerous Clinical Uses: Joint disease & injury, autoimmunity, stroke, organ failure (heart, liver, kidney & lung), MS, promotion of HSC engraftment, regenerative medicine, cancer, hearing loss, etc. • Readily Available: Blood, adipose (fat) tissue, bone marrow, teeth, etc
  • 3. GFP-Expressing Human MSCs Catalog Number SC00A4 Image: FITC of Single Human MSC GFP-Expressing Human MSCs express label in the cytoplasm. Illustrates morphological detail of human mesenchymal stem cells.
  • 4. GFP-Expressing Human MSCs FITC Image FITC + PC showing selection
  • 5. Red Fluorescent Human Mesenchymal Stem Cells Self-Renewal Transfer of label to chondrocyte (25 mM PGE2)
  • 6. MSC Growth in Low Serum MSCGro™ Compared to Lonza MSC-GM MSCGroTM at Day 3 MSCGroTM at Day 4 Lonza at Day 3 Lonza at Day 4
  • 7. Human MSC Growth in MSCGroTM vs Competitors Media: MSCGroTM results in faster growth & 2-3-fold greater cell recovery
  • 8. 160 Real Time Stability of MSCGro 140 Compared to Competitor's Medium 120 Doubling Time (Hrs) 100 MSCGro at 5% O2 MSCM-ScienCell at 5% O2 80 MSCGro at 20% O2 60 (Adipose MSCs by third party) 40 20 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 o Months at 2-8 C
  • 9. Humanized Complete & Humanized Powder MSCGro™
  • 10. Differentiation of Human MSCs Cultured in MSC-GroTM Medium Chondrocyte Stained Adipocytes Stained with Osteoblast Stained with Alcian Blue Oil Red with Alizarin Red
  • 11. Competitive Advantages of MSCGroTM • MSC growth rate/cell recovery > Lonza, InVitrogen, Stem Cell Technologies, ScienCell & ZenBio media. • MSC quality/potency (Lumenesc™) > Lonza, InVitrogen and Stem Cell Technologies media. • Vastly improved real time stability. • Medium function unaffected by freezing. • Out-performs competitors at both reduced & ambient O2 • Supports self-renewal of human, rat & mouse MSCs • Also supports primary cultures: fibroblasts (human & rat); rat cardiomyocytes & possibly hepatocytes • Provided complete & ready to use as is.